France· FR:67448384
MEGACE 160 mg, comprimé
A medicinal product containing mégestrol (acétate de), registered in France by BAUSCH HEALTH IRELAND (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉGESTROL (ACÉTATE DE)
- Manufacturer
- BAUSCH HEALTH IRELAND (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400933604721plaquette(s) thermoformée(s) PVC aluminium de 30 comprimé(s)EUR 75.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mégestrol (acétate de) in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMEGACEBausch Health Ireland Limited, Dublin
- United KingdomMegace 160mg tabletsSigma Pharmaceuticals Plc
- ItalyGESTROLTEXISTITUTO GENTILI S.R.L.
- IrelandMegace 160 mg tabletsPCO Manufacturing Ltd.
- SpainBOREA 160 mg COMPRIMIDOSViatris Healthcare Limited
- NorwayMegaceBausch Health Ireland Limited
- SwedenMegace 160 mg TablettBausch Health Ireland Ltd
- FinlandMegaceBristol-Myers Squibb Ab
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Megace
- Cyprus · Megace
- Czechia · Megace, Megaplex
- Germany · Megestat
- Spain · Borea, Maygace Altas Dosis
- United Kingdom (Northern Ireland) · Megace
- Greece · Megace
- Croatia · Megace, Megostat
- Hungary · Cachexi, Megace
- Ireland · Megace
- Italy · Gestroltex, Megace
- Lithuania · Megace
- Luxembourg · Megace
- Netherlands · Megestrolacetaat Focus
- Norway · Megace
- Poland · Cachexan, Megace
- Portugal · Megace, Megestrol Generis
- Romania · Megesin
- Sweden · Megace
- Slovenia · Megace
- Slovakia · Megesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5a2664a1-1114-4560-9519-d45ddd410852 GET /v1/drugs/5a2664a1-1114-4560-9519-d45ddd410852?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67448384",
"date_amm": "1993-03-17",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MÉGESTROL (ACÉTATE DE)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about mégestrol (acétate de).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.